[Comparative cost of treatment of chronic complicated chlamydiosis of the urogenital system with some fluoroquinolones and macrolides].
The article is devoted to the problem of the health care delivery to patients with chlamydiosis of the urogenital system. A comparative study was made of the cost of the course of treatment of chlamydiosis with different antibiotics. These included fluorochinolons cyprobai (Bayer), cyprinol (KRKA), ophloxin (Lechiva) and macrolids clacid (Sanofi-Synthelabo), phromilid (KRKA) and rovamycin (Rhone-Poulenc-Rorer). Economic expediency is proved of employment of cyprinol (KRKA) and phrolimid (KRKA), which fact is related to a high drugs clinical efficiency, quality of these drugs and optimum pricing policy carried on by the KRKA company on the market of Ukraine.
Martynenko
O V
OV
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D002689:Chlamydia / Q000187:drug effects*; D002690:Chlamydia Infections / Q000188:drug therapy / Q000191:economics*; D002908:Chronic Disease; D024841:Fluoroquinolones / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D018942:Macrolides / Q000191:economics / Q000627:therapeutic use; D014566:Urogenital System / Q000187:drug effects / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D018942:Macrolides